Share the post "Anchor Investor Transactions on 13 Sep – SUDARSHAN PHARMA INDUSTRIES"
| Company | Client name | Buy/Sell | Qty Traded | Price | Trader | Trader Category |
|---|---|---|---|---|---|---|
| Cressanda Solutions | Niraj Rajnikant Shah | Sell | 2M | 14.73 | Na | Not Available |
| Cressanda Solutions | Niraj Rajnikant Shah | Buy | 2M | 14.72 | Na | Not Available |
| Kamdhenu Ventures | Hemali Pathik Thakkar | Buy | 1M | 51.32 | Skse Securities Corp Cm/tm Prop A/c | public |
| Rajnish Wellness | Niraj Rajnikant Shah | Sell | 110K | 3.34 | Na | Not Available |
| Rajnish Wellness | Niraj Rajnikant Shah | Buy | 5M | 3.30 | Na | Not Available |
| Sudarshan Pharma Industries | Rajan Gupta | Sell | 312K | 288.20 | Globalworth Securities | public |
| Sudarshan Pharma Industries | Saroj Gupta | Sell | 608K | 288.20 | Globalworth Securities | public |
The 2M shares of Cressanda Solutions have been sold by the Niraj Rajnikant Shah at a price of ₹14.73 per share
The 2M shares of Cressanda Solutions have been purchased by the Niraj Rajnikant Shah at a price of ₹14.72 per share
The 1M shares of Kamdhenu Ventures have been purchased by the Hemali Pathik Thakkar at a price of ₹51.32 per share and it is sold by Skse Securities Corp Cm/tm Prop A/c at a price of ₹51.32 per shares. The trader belongs to public category
The 110K shares of Rajnish Wellness have been sold by the Niraj Rajnikant Shah at a price of ₹3.34 per share
The 5M shares of Rajnish Wellness have been purchased by the Niraj Rajnikant Shah at a price of ₹3.30 per share
The 312K shares of Sudarshan Pharma Industries have been sold by the Rajan Gupta at a price of ₹288.20 per share and it is purchased by Globalworth Securities at a price of ₹288.20 per shares. The trader belongs to public category
The 608K shares of Sudarshan Pharma Industries have been sold by the Saroj Gupta at a price of ₹288.20 per share and it is purchased by Globalworth Securities at a price of ₹288.20 per shares. The trader belongs to public category
Cressanda Solutions Ltd.
0.00
Net Sales
26.59
Net Profit
626.64
Total Income
-594.37
Expenditure
14.7
Current Price
611
Market Cap
The financial snapshot for Cressanda Solutions Ltd. reveals a noteworthy performance this quarter. Net sales amounted to ₹0.00 million and total income was ₹626.64 million. The company's expenditure was ₹-594.37 million, leading to a net profit of ₹26.59 million. Earnings per Share (EPS) for continuing operations were ₹0.06. The report also highlights other income of ₹11.68 million, finance costs of ₹-0.83 million, and employee benefit expenses of ₹-5.04 million. Depreciation and amortization costs were ₹-0.89 million, while current and deferred taxes were ₹-5.67 million and ₹-0.01 million, respectively. The total comprehensive income for the period stood at ₹0.00 million, with other comprehensive income net of taxes at ₹0.00 million.
The company's market cap is ₹611 crore, with a stock price of ₹14.7. The historical stock range has been between ₹28.1 / 9.55. Its Price-to-Earnings (P/E) ratio of 45.1 indicates a high valuation. The book value per share is ₹3.81, and it has a dividend yield of 0.00%. The ROCE is 9.33% and ROE is 8.64%. With a very low debt-to-equity ratio of 0.01, the company is minimally leveraged. However, it reports a negative net cash flow of ₹-0.46 crore. The Piotroski score of 4.00 and the Graham Number of ₹5.65 show mixed financial indicators, while the Price-to-Book (P/B) ratio of 3.87 suggests the stock is trading at a premium.
Kamdhenu Ventures Limited
544.57
Net Sales
15.94
Net Profit
545.88
Total Income
523.68
Expenditure
50.5
Current Price
1,586
Market Cap
For Kamdhenu Ventures Limited, the latest financial data showcases impressive results. The company reported net sales of ₹544.57 million and total income of ₹545.88 million for the quarter. Expenditure was ₹523.68 million, resulting in a net profit of ₹15.94 million. EPS for continuing operations was ₹0.05. Additional financial details include other income of ₹1.31 million, finance costs of ₹6.14 million, and employee benefit expenses of ₹83.65 million. Depreciation and amortization expenses were ₹11.94 million. Current tax was ₹7.13 million and deferred tax amounted to ₹-0.87 million. Total comprehensive income for the period was ₹15.35 million, with other comprehensive income net of taxes at ₹-0.59 million.
The company's market cap is ₹1,586 crore, with a stock price of ₹50.5. The historical stock range has been between ₹50.6 / 27.0. Its Price-to-Earnings (P/E) ratio of 119 indicates a high valuation. The book value per share is ₹5.07, and it has a dividend yield of 0.00%. The ROCE is 12.3% and ROE is 12.0%. With a very low debt-to-equity ratio of 0.13, the company is minimally leveraged. However, it reports a negative net cash flow of ₹5.14 crore. The Piotroski score of 6.00 and the Graham Number of ₹6.94 show mixed financial indicators, while the Price-to-Book (P/B) ratio of 9.96 suggests the stock is trading at a premium.
Rajnish Wellness Limited
0.00
Net Sales
1.67
Net Profit
166.50
Total Income
-164.27
Expenditure
4.54
Current Price
349
Market Cap
The financial snapshot for Rajnish Wellness Limited reveals a noteworthy performance this quarter. Net sales amounted to ₹0.00 million and total income was ₹166.50 million. The company's expenditure was ₹-164.27 million, leading to a net profit of ₹1.67 million. Earnings per Share (EPS) for continuing operations were ₹0.00. The report also highlights other income of ₹3.47 million, finance costs of ₹-1.30 million, and employee benefit expenses of ₹-1.25 million. Depreciation and amortization costs were ₹-0.03 million, while current and deferred taxes were ₹-0.56 million and ₹0.00 million, respectively. The total comprehensive income for the period stood at ₹0.00 million, with other comprehensive income net of taxes at ₹0.00 million.
Currently valued at ₹349 crore, the company's stock price is ₹4.54. It has seen a price range of ₹15.3 / 4.32 over time. The stock's Price-to-Earnings (P/E) ratio is notably high at 537, implying a strong valuation. The book value per share is ₹1.09 and the dividend yield is 0.00%. ROCE is recorded at 2.28%, and ROE stands at 1.23%. The company maintains a very low debt-to-equity ratio of 0.06, though it has a negative net cash flow of ₹-0.11 crore. The Piotroski score of 8.00 and the Graham Number of ₹0.46 suggest some caution, while the Price-to-Book (P/B) ratio of 4.15 reflects a premium valuation.
